The Research and Development team at oNKo-innate is focused on pioneering innovative immuno-oncology therapies by leveraging their expertise in Natural Killer (NK) cell biology. This multidisciplinary team engages in target identification, conducts pre-clinical studies, and utilizes computational biology to enhance drug design and efficacy, all aimed at advancing the company’s mission to optimize cancer treatment through NK cell therapeutics.